Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid claims: sources

France Nouvelles Nouvelles

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid claims: sources
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

OxyContin maker Purdue Pharma and its owners, the Sackler family, is in discussi...

- OxyContin maker Purdue Pharma and its owners, the Sackler family, is in discussion to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday.

Purdue said it was actively working with state attorneys general and other plaintiffs to reach a resolution, without specifying a settlement amount. Purdue reached a settlement in March for $270 million to resolve a similar lawsuit by the state of Oklahoma. Attorney Mary Jo White, who represents one wing of the Sackler family in the opioid litigation, declined to comment on the reported settlement offer. A Sackler spokeswoman also declined to comment.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Purdue Pharma offers $10-12 billion to settle opioid claimsPurdue Pharma offers $10-12 billion to settle opioid claimsPurdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10B to $12B, according to 2 people familiar with the mediation.
Lire la suite »

It Is Too Early for Pharma Investors to Cheer Opioid VerdictIt Is Too Early for Pharma Investors to Cheer Opioid VerdictHold the celebration: The opioid litigation cloud hanging over drug stocks won’t clear up soon, despite an Oklahoma judge’s ruling that Johnson & Johnson is liable for fueling the opioid crisis.
Lire la suite »

Shares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fineShares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fineShares of major pharmaceutical companies surged in after-hours trading Monday following a smaller-than-expected fine for Johnson & Johnson.
Lire la suite »

Purdue Pharma offers $10-12 billion to settle opioid claimsPurdue Pharma offers $10-12 billion to settle opioid claimsPurdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10B to $12B, according to 2 people familiar with the mediation.
Lire la suite »



Render Time: 2025-04-08 10:54:11